*ST敦種(600354.SH)擬定增募資不超4.62億元 首農股份將成為公司第一大股東
格隆匯4月15日丨*ST敦種(600354.SH)發佈非公開發行A股股票預案,擬發行數量不超過約1.5834億(含),不超過此次發行前公司總股本的30%,且募集資金總額不超過約4.62億元(含),非公開發行股票的發行價格為2.92元/股。發行對象為首農股份。
扣除發行費用後的募集資金淨額將用於補充運營資金和償還銀行貸款。
此次發行後,公司的控股股東、實際控制人將發生變更,首農股份將成為公司第一大股東、控股股東,北京市國資委將成為上市公司的實際控制人,原控股股東酒泉地區現代農業(控股集團)有限責任公司持股比例將從12.92%下降到9.94%,不會導致公司股權分佈不具備上市條件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.